U.S. Orthopedic Joint Replacement Market Size, Share & COVID-19 Impact Analysis, By Product (Knee, Hip, Shoulder, Ankle, and Others), By Procedure (Total, Partial, and Others), By End User (Hospitals & ASCs, Orthopedic Clinics, and Others), and Country Forecast, 2023-2030

The U.S. orthopedic joint replacement market size was worth USD 5.98 billion in 2022 and is projected to grow at a CAGR of 7.9% during the forecast period. 

The number of orthopedic joint replacement surgeries has significantly increased in the past few years and is expected to rise in the coming years. Furthermore, an increasing number of adults aged 65 and older in the country is augmenting the orthopedic joint replacement market growth due to the increasing instances of hip fractures in the elderly population.

• According to a study published in September 2021, the number of Total Knee Arthroplasty (TKA) procedures in the U.S. is projected to reach 1,531,566 procedures in 2050, with an increase of 143% from 631,214 procedures in 2012.

Moreover, the introduction of patient-specific 3D printed implants and technological innovations in robotic surgery also support the market growth.

The COVID-19 pandemic negatively impacted the U.S. orthopedic joint replacement market due to cancellation and delay of elective orthopedic surgeries. The market players also witnessed a decline in their revenues due to the pandemic. However, with the decreasing number of COVID-19 cases and the lifting of movement restrictions, the market gained its pace and is expected to grow steadily in the coming years.

LATEST TRENDS

Emphasis on Development of Innovative Products 

In recent years, the demand for customized products for orthopedic joint replacement is significantly increasing. As the concept of “one size fits all” is not applicable due to the unique anatomy of every patient, the manufacturers are shifting their focus to the development of innovative products to cater to unmet market needs.

• For instance, in November 2022, Imprint Knee System was introduced by ConforMIS Inc. in the U.S. Along with this, a “Made-to-Measure” product category option for Total Knee Arthroplasty (TKA) was also launched by the company.

DRIVING FACTORS

Request a Free sample to learn more about this report.

Increasing Adoption of Robotic Surgeries to Propel Market Growth

One of the significant driving factors for the U.S. market is the increasing adoption of robotic orthopedic surgeries. The use of surgical robots in orthopedic joint replacement procedures increases the efficiency of these procedures and results in better outcomes. This has resulted in an increasing number of hospitals offering robotic surgeries for orthopedic indications.

• According to an article published by Max Healthcare in December 2022, in the U.S., more than 600,000 robotic hip and knee replacement procedures are performed annually. This number is expected to increase by 673% in 2030.

Furthermore, owing to the increasing number of robotic surgeries, market players are focusing on the development and commercialization of robotic surgery products to aid in orthopedic replacement procedures.

• For instance, in October 2022, THINK Surgical received an investment of USD 100 million from KDB Investment Global Healthcare of Korea to accelerate the commercialization of robotic surgery products.

According to the American Joint Replacement Registry 2022 Annual Report, the number of knee arthroplasty procedures between 2012 and 2021 reached 1,495,965.

RESTRAINING FACTORS

Recent Product Recalls to Impede Growth Prospects 

One of the key factors restraining the U.S. market growth is the recall of hip and knee replacement devices by major players. This factor is limiting the market growth to a certain extent.

Faulty designs, improper fit, packaging errors, loosening, early wear, and co-mingled components are some reasons for product recalls by manufacturers.

• For instance, in August 2022, Exatech expanded its product recall notice to include all hip replacement devices with polyethylene components that were packaged in defective bags.

SEGMENTATION

By Product Analysis

On the basis of product, the market is segmented into knee, hip, shoulder, ankle, and others.

In 2022, the knee segment captured the highest U.S. orthopedic joint replacement market share. The high prevalence of chronic knee-related diseases in the country resulted in an increasing demand for knee replacement procedures.

• For instance, as per the data published by the American Joint Replacement Registry in its 2022 Annual Report, between 2012 and 2021, a total of 1,495,965 knee arthroplasty procedures were performed in the U.S.

On the other hand, the shoulder segment is anticipated to witness strong growth during the forecast period. In the U.S., the number of individuals undergoing Total Shoulder Arthroplasty (TSA) with obesity continues to grow every year. This is one of the factors supplementing the segment growth.

• For instance, as per the study published in the Journal of Shoulder and Elbow Surgery in September 2022, from 2010 to October 2020, 13,634 patients underwent TSA. The percentage of obese patients undergoing surgery reached 34% in 2019.

By Procedure Analysis

Based on procedure, the market is segmented into total, partial, and others.

The total segment held the dominating position in the market in 2022. According to various articles, total replacement is the most commonly performed procedure in the U.S. This procedure reduces the possibility of developing arthritis.

On the other hand, the partial segment would exhibit the fastest growth over the forecast period. This can be attributed to the increasing adoption of partial replacement among patients and healthcare professionals owing to its advantages over total replacement procedures. Some of the advantages include less invasive procedures leading to faster recovery time, fewer serious surgical complications, lower risk of infection, and others.

By End User Analysis

On the basis of end user, the market is subdivided into orthopedic clinics, hospitals & ASCs, and others.

In 2022, the hospitals & ASCs segment accounted for the largest U.S. orthopedic joint replacement market share. A few factors contributing to its dominance include a growing number of surgeries in hospitals coupled with increasing adoption of the latest technologies by skilled healthcare professionals.

• For instance, in August 2022, NYC Health + Hospitals/Elmhurst announced the installation of the Stryker Mako SmartRobotics system for knee and hip replacement surgeries.

The orthopedic clinics segment is estimated to witness a significant growth rate during the forecast period. The increasing number of surgeries in clinics in areas where access to medical facilities is limited is driving the segment growth.

KEY INDUSTRY PLAYERS

The competitive landscape for the orthopedic joint replacement market in the U.S. is highly consolidated. Prominent players, such as Stryker, Zimmer Biomet, Johnson & Johnson Services, Inc., and Smith & Nephew, dominated the market with a noteworthy share in 2022. Factors contributing to the dominance of these players include diversified product offerings along with a focus on the introduction of innovative products to strengthen their market position.

Some other key players operating in the market include B. Braun SE, Conformis, Enovis, Exatech, Meril Life, and others. These companies are focusing on expanding their product portfolio to enhance their market presence.

• For instance, in August 2022, Extech announced the first successful surgeries of its Logical Cup System and Spartan Stem System for total hip arthroplasty.

LIST OF KEY COMPANIES PROFILED:

• Stryker (U.S.)


• Johnson & Johnson Services, Inc. (U.S.)


• Smith + Nephew (U.K.)


• Zimmer Biomet (U.S.)


• B. Braun SE (Germany)


• Conformis (U.S.)


• Enovis (U.S.)

KEY INDUSTRY DEVELOPMENTS: 

• November 2022 – The U.S. FDA granted the 510(k) clearance to Zimmer Biomet Holdings, Inc.’s Persona OsseoTi Keel Tibia for cement-less knee replacement.


• September 2022 – Zimmer Biomet signed a multi-year co-marketing agreement with Surgical Planning for total hip replacement.


• September 2020 – THINK Surgical, Inc. and Total Joint Orthopedics (TJO) announced a collaboration for the enhancement of total knee replacement procedures.

REPORT COVERAGE

An Infographic Representation of U.S. Orthopedic Joint Replacement Market

View Full Infographic

To get information on various segments, share your queries with us

The U.S. orthopedic joint replacement market research report provides a detailed analysis of the market. It focuses on key segments such as product type, procedure, and end user. In addition, it includes detailed insights on market dynamics, new product launches, key industry developments such as mergers, partnerships, and acquisitions, and the impact of COVID-19 on the market. Besides this, the report offers insights into the regulatory and reimbursement scenarios for the U.S. The report also provides the competitive landscape.

Report Scope & Segmentation